Cargando…
Innovation in cancer therapeutics and regulatory perspectives
Cancer therapy has undergone a drastic revolution in the past few decades with the introduction of several novel therapies, like immunotherapy (active and passive), stem cell-based therapies, and nanocarrier-based therapies. These therapies have addressed the issues of conventional cancer therapy (c...
Autores principales: | Sharma, Pinky, Jhawat, Vikas, Mathur, Pooja, Dutt, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863908/ https://www.ncbi.nlm.nih.gov/pubmed/35195787 http://dx.doi.org/10.1007/s12032-022-01677-0 |
Ejemplares similares
-
Utilization of kinase inhibitors as novel therapeutic drug targets: A review
por: NISHAL, SUCHITRA, et al.
Publicado: (2023) -
Therapeutic gene editing: delivery and regulatory perspectives
por: Shim, Gayong, et al.
Publicado: (2017) -
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices
por: Deshayes, Emmanuel, et al.
Publicado: (2023) -
T-Regulatory Cells In Tumor Progression And Therapy
por: Verma, Amit, et al.
Publicado: (2019) -
Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019)